Tolnaftate 10 MG/ML Topical Cream — RxCUI 103951
RxNorm drug concept · Semantic clinical drug
RxCUI 103951
Semantic clinical drug · SCD
● Current RxNorm concept 51 FDA products
66 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI103951
Official nameTolnaftate 10 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astolnaftate 1 % Topical Cream
FDA products mapped51
Package NDCs mapped66
Reported Medicaid activity (SDUD)5,131 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tolnaftate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on what you're treating. For athlete's foot and ringworm, plan on using it daily for about 4 weeks. For jock itch, 2 weeks is the usual course. Some products mention you...
- How long does it take for tolnaftate to work?
- Tolnaftate is not effective for treating infections on the scalp or on the nails themselves — most products say so right on the label. Some liquid and patch products are designed t...
- Stop applying the product and let your doctor know. A little initial sensitivity can happen, but worsening irritation is a sign that you should get it checked out. Don't push throu...
🕸️ Concept Web — How Tolnaftate 10 MG/ML Topical Cream Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tolnaftate 10 MG/ML Topical Cream
RxCUI 103951 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Tolnaftate
10637IN
-
Tolnaftate
-
Brand names 7
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Absorbine Jr. Antifungal
214954BN -
Clarus
1299055BN -
Fungi-Guard
217218BN -
Hongo Killer Antifungal
1101779BN -
Lamisil Defense
692846BN -
Tinactin
220322BN -
Tritolnacide
2679329BN
-
Absorbine Jr. Antifungal
-
Dose forms 18
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tolnaftate Topical Cream
377826SCDF -
Tolnaftate Topical Product
1157650SCDG -
Tolnaftate Topical Cream [Absorbine Jr. Antifungal]
762421SBDF -
Tolnaftate Topical Cream [Clarus]
1299057SBDF -
Tolnaftate Topical Cream [Fungi-Guard]
362191SBDF -
Tolnaftate Topical Cream [Hongo Killer Antifungal]
1101781SBDF -
Tolnaftate Topical Cream [Lamisil Defense]
866322SBDF -
Tolnaftate Topical Cream [Tinactin]
362112SBDF - +10 more in this family
-
Tolnaftate Topical Cream
-
Clinical & branded drugs 15
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tolnaftate 10 MG/ML
328892SCDC -
Tolnaftate 10 MG/ML Topical Cream [Absorbine Jr. Antifungal]
762422SBD -
Tolnaftate 10 MG/ML Topical Cream [Clarus]
1299059SBD -
Tolnaftate 10 MG/ML Topical Cream [Fungi-Guard]
209645SBD -
Tolnaftate 10 MG/ML Topical Cream [Hongo Killer Antifungal]
1101782SBD -
Tolnaftate 10 MG/ML Topical Cream [Lamisil Defense]
866323SBD -
Tolnaftate 10 MG/ML Topical Cream [Tinactin]
209651SBD -
Tolnaftate 10 MG/ML Topical Cream [Tritolnacide]
2685262SBD - +7 more in this family
-
Tolnaftate 10 MG/ML
Showing up to 8 concepts per family — 24 of 41 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tolnaftate 10 MG/ML
SCDC · 328892 -
Tolnaftate Topical Cream
SCDF · 377826 -
Tolnaftate Topical Product
SCDG · 1157650
Brand-Name Concepts
-
Tolnaftate 10 MG/ML Topical Cream [Clarus]
SBD · 1299059 -
Tolnaftate 10 MG/ML Topical Cream [Hongo Killer Antifungal]
SBD · 1101782 -
Tolnaftate 10 MG/ML Topical Cream [Tinactin]
SBD · 209651 -
Tolnaftate 10 MG/ML Topical Cream [Tritolnacide]
SBD · 2685262 -
Tolnaftate 10 MG/ML Topical Cream [Absorbine Jr. Antifungal]
SBD · 762422 -
Tolnaftate 10 MG/ML Topical Cream [Fungi-Guard]
SBD · 209645 -
Tolnaftate 10 MG/ML Topical Cream [Lamisil Defense]
SBD · 866323 -
Tolnaftate 10 MG/ML [Absorbine Jr. Antifungal]
SBDC · 570250 -
Tolnaftate 10 MG/ML [Clarus]
SBDC · 1299056 -
Tolnaftate 10 MG/ML [Fungi-Guard]
SBDC · 570233
📦 FDA Products & Package NDCs
51 products · 66 package NDCs
66 package NDCs map to RxCUI 103951 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 70677-1001-01 | 1 TUBE in 1 CARTON (70677-1001-1) / 15 g in 1 TUBE | Tolnaftate Antifungal | STRATEGIC SOURCING SERVICES LLC | 2023-06-22 |
| 71101-0017-01 | 1 TUBE in 1 CARTON (71101-017-01) / 35.4 g in 1 TUBE | TheraCare Antifungal Cream | Veridian Healthcare | 2025-10-01 |
| 71229-0103-11 | 28 g in 1 TUBE (71229-103-11) | FUNGINIX AF | The Sisquoc Healthcare Corporation | 2019-03-25 |
| 71229-0104-11 | 28 g in 1 TUBE (71229-104-11) | FUNGINIX JOCK ITCH TREATMENT | The Sisquoc Healthcare Corporation | 2019-03-25 |
| 73352-0561-10 | 1 BOTTLE, WITH APPLICATOR in 1 POUCH (73352-561-10) / 37 mL... | TriTolnacide C | Trifluent Pharma LLC | 2024-06-17 |
| 73469-0618-01 | 1 BOTTLE in 1 CARTON (73469-0618-1) / 28.3 g in 1 BOTTLE | Dr.Scholl s Odor X Athlete s Foot | Scholl's Wellness Company LLC | 2026-02-15 |
| 80684-0040-01 | 1 TUBE in 1 BOX (80684-040-01) / 14 g in 1 TUBE | Thera plus Antifungal Tolnaftate | FOURSTAR GROUP USA, INC. | 2022-01-30 |
| 81929-0004-01 | 1 TUBE in 1 CARTON (81929-004-01) / 50 g in 1 TUBE | Derman antifungal cream | Taisho Pharmaceutical California Inc. | 2022-07-01 |
| 81929-0004-02 | 1 TUBE in 1 CARTON (81929-004-02) / 25 g in 1 TUBE | Derman antifungal cream | Taisho Pharmaceutical California Inc. | 2022-07-01 |
| 82442-0020-28 | 1 TUBE in 1 CARTON (82442-020-28) / 28 g in 1 TUBE | Up and Up Antifungal | Target Corporation | 2024-08-01 |
| 83324-0049-01 | 1 TUBE in 1 BOX (83324-049-01) / 28.3 g in 1 TUBE | Antifungal | Chain Drug Marketing Association Inc. | 2024-05-31 |
| 85248-0068-01 | 30 mL in 1 BOTTLE (85248-068-01) | SYLVIRENE FUNGAL NAIL RENEWAL | Jiangxi Yudexi Pharmaceutical Co., LTD | 2026-02-07 |
| 85384-0008-01 | 100 g in 1 TUBE (85384-0008-1) | Tagrid Athletes Foot Treament | TAGRID LLC | 2025-05-30 |
| 85398-0017-01 | 60 g in 1 CARTON (85398-017-01) | Initial Drug Listing - Hermon Athletes foot 1% tolnaftate cream | Beautivity LLC | 2025-10-31 |
| 85398-0017-02 | 57 g in 1 TUBE (85398-017-02) | Initial Drug Listing - Hermon Athletes foot 1% tolnaftate cream | Beautivity LLC | 2025-10-31 |
| 85398-0018-01 | 1 KIT in 1 CARTON (85398-018-01) * 57 g in 1 TUBE (85398-0... | Hermon Athletes foot Tolnaftate 1% kit | Beautivity LLC | 2025-10-31 |
Observed labelers:
Trifecta Pharmaceuticals Usa Llc (4) ·
Bayer HealthCare LLC. (3) ·
Beautivity LLC (3) ·
Efficient Laboratories Inc (3) ·
A-S Medication Solutions (2) ·
Clinical Therapeutic Solutions (2)
· +38 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.